Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.

ABSTRACT:

Background

Retrospective studies provide conflicting interpretations of the effect of inherited genetic factors on the prognosis of patients with breast cancer. The primary aim of this study was to determine the effect of a germline BRCA1 or BRCA2 mutation on breast cancer outcomes in patients with young-onset breast cancer.

Methods

We did a prospective cohort study of female patients recruited from 127 hospitals in the UK aged 40 years or younger at first diagnosis (by histological confirmation) of invasive breast cancer. Patients with a previous invasive malignancy (except non-melanomatous skin cancer) were excluded. Patients were identified within 12 months of initial diagnosis. BRCA1 and BRCA2 mutations were identified using blood DNA collected at recruitment. Clinicopat

SUBMITTER: Copson ER 

PROVIDER: S-EPMC5805863 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature